Respiratory syncytial virus modifies microRNAs regulating host genes that affect virus replication

Journal of General Virology

Volumn 93, Issue PART 11, 2012, Pages 2346-2356

  Bakre, Abhijeet ^a   Mitchell, Patricia ^a   Coleman, Jonathan K ^a   Jones, Les P ^a   Saavedra, Geraldine ^a   Teng, Michael ^b   Tompkins Mark, S ^a   Tripp, Ralph A ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; LUCIFERASE; MICRORNA; MICRORNA 198; MICRORNA 24; MICRORNA 26B; MICRORNA 337; MICRORNA 520A; MICRORNA 595; MICRORNA LET 7F; MONOCYTE CHEMOTACTIC PROTEIN 3; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG;

ARTICLE; EPITHELIUM CELL; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; UNTRANSLATED REGION; VIRUS GENE; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; BASE SEQUENCE; CELL LINE; CERCOPITHECUS AETHIOPS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, VIRAL; HUMANS; MICRORNAS; PULMONARY ALVEOLI; RESPIRATORY SYNCYTIAL VIRUSES; RNA PROCESSING, POST-TRANSCRIPTIONAL; VERO CELLS; VIRUS REPLICATION;

EID: 84867491456     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.044255-0     Document Type: Article

References (66)

1. Alvarez, R., Elbashir, S., Borland, T., Toudjarska, I., Hadwiger, P., John, M., Roehl, I., Morskaya, S. S., Martinello, R. & other authors (2009). RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy. Antimicrob Agents Chemother 53, 3952-3962.
2. Asirvatham, A. J., Magner, W. J. & Tomasi, T. B. (2009). miRNA regulation of cytokine genes. Cytokine 45, 58-69.
3. Becker, Y. (2006). Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy-a review. Virus Genes 33, 235-252.
4. Berezikov, E., Chung, W.-J., Willis, J., Cuppen, E. & Lai, E. C. (2007). Mammalian mirtron genes. Mol Cell 28, 328-336.
5. Bossert, B., Marozin, S. & Conzelmann, K. K. (2003). Nonstructural proteins NS1 and NS2 of bovine respiratory syncytial virus block activation of interferon regulatory factor 3. J Virol 77, 8661-8668.
6. CDCP (2008). Respiratory syncytial virus activity-United States, July 2007-December 2008. MMWR Morb Mortal Wkly Rep 57, 1355-1358.
7. Dölken, L., Malterer, G., Erhard, F., Kothe, S., Friedel, C. C., Suffert, G., Marcinowski, L., Motsch, N., Barth, S. & Beitzinger, M. (2010). Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay. Cell Host Microbe 7, 324-334.
8. Elliott, J., Lynch, O. T., Suessmuth, Y., Qian, P., Boyd, C. R., Burrows, J. F., Buick, R., Stevenson, N. J., Touzelet, O. & other authors (2007). Respiratory syncytial virus NS1 protein degrades STAT2 by using the elongin-cullin E3 ligase. J Virol 81, 3428-3436.
9. Fabian, M. R., Sonenberg, N. & Filipowicz, W. (2010). Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79, 351-379.
10. Fjaerli, H. O., Bukholm, G., Skjaeret, C., Holden, M. & Nakstad, B. (2007). Cord blood gene expression in infants hospitalized with respiratory syncytial virus bronchiolitis. J Infect Dis 196, 394-404.
11. Friedman, R. C., Farh, K. K., Burge, C. B. & Bartel, D. P. (2009). Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19, 92-105.
12. Gibbs, J. D., Ornoff, D. M., Igo, H. A., Zeng, J. Y. & Imani, F. (2009). Cell cycle arrest by transforming growth factor b1 enhances replication of respiratory syncytial virus in lung epithelial cells. J Virol 83, 12424-12431.
13. Griffiths-Jones, S., Saini, H. K., van Dongen, S. & Enright, A. J. (2008). miRBase: tools for microRNA genomics. Nucleic Acids Res 36 (Database issue), D154-D158.
14. Groskreutz, D. J., Monick, M. M., Yarovinsky, T. O., Powers, L. S., Quelle, D. E., Varga, S. M., Look, D. C. & Hunninghake, G. W. (2007). Respiratory syncytial virus decreases p53 protein to prolong survival of airway epithelial cells. J Immunol 179, 2741-2747.
15. Hallak, L. K., Spillmann, D., Collins, P. L. & Peeples, M. E. (2000). Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J Virol 74, 10508-10513.
16. Hamada, N., Fujita, Y., Kojima, T., Kitamoto, A., Akao, Y., Nozawa, Y. & Ito, M. (2012). MicroRNA expression profiling of NGF-treated PC12 cells revealed a critical role for miR-221 in neuronal differentiation. Neurochem Int 60, 743-750.
17. +T cell responses. J Immunol 176, 1600-1608.
18. Hedvat, C. V., Yao, J., Sokolic, R. A. & Nimer, S. D. (2004). Myeloid ELF1-like factor is a potent activator of interleukin-8 expression in hematopoietic cells. J Biol Chem 279, 6395-6400.
19. Huang, Y.-C., Li, Z., Hyseni, X., Schmitt, M., Devlin, R. B., Karoly, E. D. & Soukup, J. M. (2008). Identification of gene biomarkers for respiratory syncytial virus infection in a bronchial epithelial cell line. Genomic Med 2, 113-125.
20. Janssen, R., Pennings, J., Hodemaekers, H., Buisman, A., van Oosten, M., de Rond, L., Oztürk, K., Dormans, J., Kimman, T. & Hoebee, B. (2007). Host transcription profiles upon primary respiratory syncytial virus infection. J Virol 81, 5958-5967.
21. Johnson, T. R. & Graham, B. S. (2004). Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection. Pediatr Infect Dis J 23 (Suppl.), S46-S57.
22. Johnson, C. D., Esquela-Kerscher, A., Stefani, G., Byrom, M., Kelnar, K., Ovcharenko, D., Wilson, M., Wang, X., Shelton, J. & other authors (2007). The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 67, 7713-7722.
23. Jopling, C. L., Norman, K. L. & Sarnow, P. (2006). Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122. Cold Spring Harb Symp Quant Biol 71, 369-376.
24. Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C. & other authors (2005). Combinatorial microRNA target predictions. Nat Genet 37, 495-500.
25. Kurt-Jones, E. A., Popova, L., Kwinn, L., Haynes, L. M., Jones, L. P., Tripp, R. A., Walsh, E. E., Freeman, M. W., Golenbock, D. T. & other authors (2000). Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 1, 398-401.
26. Lagos, D., Pollara, G., Henderson, S., Gratrix, F., Fabani, M., Milne, R. S., Gotch, F. & Boshoff, C. (2010). miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional coactivator. Nat Cell Biol 12, 513-519.
27. Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A. O. & other authors (2007). A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401-1414.
28. Lewis, B. P., Burge, C. B. & Bartel, D. P. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20.
29. Li, X.-Q., Fu, Z. F., Alvarez, R., Henderson, C. & Tripp, R. A. (2006). Respiratory syncytial virus (RSV) infects neuronal cells and processes that innervate the lung by a process involving RSV G protein. J Virol 80, 537-540.
30. Li, Q., Brass, A. L., Ng, A., Hu, Z., Xavier, R. J., Liang, T. J. & Elledge, S. J. (2009). A genome-wide genetic screen for host factors required for hepatitis C virus propagation. Proc Natl Acad Sci U S A 106, 16410-16415.
31. Lindquist, M. E., Lifland, A. W., Utley, T. J., Santangelo, P. J. & Crowe, J. E., Jr (2010). Respiratory syncytial virus induces host RNA stress granules to facilitate viral replication. J Virol 84, 12274-12284.
32. Lindquist, M. E., Mainou, B. A., Dermody, T. S. & Crowe, J. E., Jr (2011). Activation of protein kinase R is required for induction of stress granules by respiratory syncytial virus but dispensable for viral replication. Virology 413, 103-110.
33. Lo, M. S., Brazas, R. M. & Holtzman, M. J. (2005). Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J Virol 79, 9315-9319.
34. Maddika, S. & Chen, J. (2009). Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase. Nat Cell Biol 11, 409-419.
35. Marti{dotless}́nez, I., Lombardi{dotless}́a, L., Garci{dotless}́a-Barreno, B., Domi{dotless}́nguez, O. & Melero, J. A. (2007). Distinct gene subsets are induced at different time points after human respiratory syncytial virus infection of A549 cells. J Gen Virol 88, 570-581.
36. Meliopoulos, V. A., Andersen, L. E., Birrer, K. F., Simpson, K. J., Lowenthal, J. W., Bean, A. G., Stambas, J., Stewart, C. R., Tompkins, S. M. & other authors (2012). Host gene targets for novel influenza therapies elucidated by high-throughput RNA interference screens. FASEB J 26, 1372-1386.
37. Mohapatra, S., Park, S. J., Boyapalle, S., Pastey, M. K., Graham, B. S. & Blanck, G. (2009). Human respiratory syncytial virus reduces the number of cells in S-phase and increases GADD153 expression in HEp-2 cells. Acta Virol 53, 207-211.
38. Moore, E. C., Barber, J. & Tripp, R. A. (2008). Respiratory syncytial virus (RSV) attachment and nonstructural proteins modify the type I interferon response associated with suppressor of cytokine signaling (SOCS) proteins and IFN-stimulated gene-15 (ISG15). Virol J 5, 116.
39. Morlando, M., Ballarino, M., Gromak, N., Pagano, F., Bozzoni, I. & Proudfoot, N. J. (2008). Primary microRNA transcripts are processed co-transcriptionally. Nat Struct Mol Biol 15, 902-909.
40. Munday, D. C., Emmott, E., Surtees, R., Lardeau, C. H., Wu, W., Duprex, W. P., Dove, B. K., Barr, J. N. & Hiscox, J. A. (2010). Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus. Mol Cell Proteomics 9, 2438-2459.
41. Murawski, M. R., Bowen, G. N., Cerny, A. M., Anderson, L. J., Haynes, L. M., Tripp, R. A., Kurt-Jones, E. A. & Finberg, R. W. (2009). Respiratory syncytial virus activates innate immunity through Tolllike receptor 2. J Virol 83, 1492-1500.
42. O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G. & Baltimore, D. (2007). MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 104, 1604-1609.
43. Oshansky, C. M., Krunkosky, T. M., Barber, J., Jones, L. P. & Tripp, R. A. (2009a). Respiratory syncytial virus proteins modulate suppressors of cytokine signaling 1 and 3 and the type I interferon response to infection by a Toll-like receptor pathway. Viral Immunol 22, 147-161.
44. Oshansky, C. M., Zhang, W., Moore, E. & Tripp, R. A. (2009b). The host response and molecular pathogenesis associated with respiratory syncytial virus infection. Future Microbiol 4, 279-297.
45. Othumpangat, S., Gibson, L. F., Samsell, L. & Piedimonte, G. (2009). NGF is an essential survival factor for bronchial epithelial cells during respiratory syncytial virus infection. PLoS ONE 4, e6444.
46. Othumpangat, S., Walton, C. & Piedimonte, G. (2012). MicroRNA-221 modulates RSV replication in human bronchial epithelium by targeting NGF expression. PLoS ONE 7, e30030.
47. Panda, D., Das, A., Dinh, P. X., Subramaniam, S., Nayak, D., Barrows, N. J., Pearson, J. L., Thompson, J., Kelly, D. L. & other authors (2011). RNAi screening reveals requirement for host cell secretory pathway in infection by diverse families of negative-strand RNA viruses. Proc Natl Acad Sci U S A 108, 19036-19041.
48. Roberts, S. R., Lichtenstein, D., Ball, L. A. & Wertz, G. W. (1994). The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons. J Virol 68, 4538-4546.
49. Roberts, A. P., Lewis, A. P. & Jopling, C. L. (2011). miR-122 activates hepatitis C virus translation by a specialized mechanism requiring particular RNA components. Nucleic Acids Res 39, 7716-7729.
50. Selbach, M., Schwanhäusser, B., Thierfelder, N., Fang, Z., Khanin, R. & Rajewsky, N. (2008). Widespread changes in protein synthesis induced by microRNAs. Nature 455, 58-63.
51. Spann, K. M., Tran, K. C. & Collins, P. L. (2005). Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-kB, and proinflammatory cytokines. J Virol 79, 5353-5362.
52. Taganov, K. D., Boldin, M. P., Chang, K.-J. & Baltimore, D. (2006). NF-kB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 103, 12481-12486.
53. Taira, N., Nihira, K., Yamaguchi, T., Miki, Y. & Yoshida, K. (2007). DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage. Mol Cell 25, 725-738.
54. Taura, M., Suico, M. A., Fukuda, R., Koga, T., Shuto, T., Sato, T., Morino-Koga, S., Okada, S. & Kai, H. (2011). MEF/ELF4 transactivation by E2F1 is inhibited by p53. Nucleic Acids Res 39, 76-88.
55. Tayyari, F., Marchant, D., Moraes, T. J., Duan, W., Mastrangelo, P. & Hegele, R. G. (2011). Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat Med 17, 1132-1135.
56. Terasawa, K., Ichimura, A., Sato, F., Shimizu, K. & Tsujimoto, G. (2009). Sustained activation of ERK1/2 by NGF induces microRNA-221 and 222 in PC12 cells. FEBS J 276, 3269-3276.
57. Triboulet, R., Mari, B., Lin, Y.-L., Chable-Bessia, C., Bennasser, Y., Lebrigand, K., Cardinaud, B., Maurin, T., Barbry, P. & other authors (2007). Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 315, 1579-1582.
58. Tripp, R. A., Moore, D., Jones, L., Sullender, W., Winter, J. & Anderson, L. J. (1999). Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice. J Virol 73, 7099-7107.
59. Tripp, R. A., Jones, L. & Anderson, L. J. (2000a). Respiratory syncytial virus G and/or SH glycoproteins modify CC and CXC chemokine mRNA expression in the BALB/c mouse. J Virol 74, 6227-6229.
60. Tripp, R. A., Moore, D., Winter, J. & Anderson, L. J. (2000b). Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice. J Virol 74, 1614-1622.
61. Tripp, R. A., Jones, L. P., Haynes, L. M., Zheng, H., Murphy, P. M. & Anderson, L. J. (2001). CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat Immunol 2, 732-738.
62. +T cell responses. J Immunol 165, 6487-6495.
63. Vermeulen, A., Robertson, B., Dalby, A. B., Marshall, W. S., Karpilow, J., Leake, D., Khvorova, A. & Baskerville, S. (2007). Double-stranded regions are essential design components of potent inhibitors of RISC function. RNA 13, 723-730.
64. Wu, W., Munday, D. C., Howell, G., Platt, G., Barr, J. N. & Hiscox, J. A. (2011). Characterization of the interaction between human respiratory syncytial virus and the cell cycle in continuous cell culture and primary human airway epithelial cells. J Virol 85, 10300-10309.
65. Zhang, C., Zhang, J., Zhang, A., Wang, Y., Han, L., You, Y., Pu, P. & Kang, C. (2010a). PUMA is a novel target of miR-221/222 in human epithelial cancers. Int J Oncol 37, 1621-1626.
66. Zhang, J., Han, L., Ge, Y., Zhou, X., Zhang, A., Zhang, C., Zhong, Y., You, Y., Pu, P. & Kang, C. (2010b). miR-221/222 promote malignant progression of glioma through activation of the Akt pathway. Int J Oncol 36, 913-920.